Cancer Immunology Research · 2020 · 15 citations · 37 references
Life SciencesImmunologyOncologyImmunizationImmunotherapyVaccinologyCancer ImmunotherapyCancer VaccinesT Cell Responses To TumorsTumor AntigensTumor-associated AntigensVaccine-based ImmunotherapyCd8 Positive T CellsDendritic Cell Neoantigen VaccinesImmunogenicity Of Tumor AntigensNeoantigen ImmunotherapyTumor Antigen RecognitionTumor Antigen VaccinesTumor ImmunogenicityVaccination Strategies
Abstract Vaccination of patients against neoantigens expressed in concurrent tumors, recurrent tumors, or tumors developing in individuals at risk of cancer is posing major challenges in terms of which antigens to target and is limited to patients expressing neoantigens in their tumors. Here, we describe a vaccination strategy against antigens that were induced in tumor cells by downregulation of the peptide transporter associated with antigen processing (TAP). Vaccination against TAP downregulation–induced antigens was more effective than vaccination against mutation-derived neoantigens, was devoid of measurable toxicity, and inhibited the growth of concurrent and future tumors in models of recurrence and premalignant disease. Human CD8+ T cells stimulated with TAPlow dendritic cells elicited a polyclonal T-cell response that recognized tumor cells with experimentally reduced TAP expression. Vaccination against TAP downregulation–induced antigens overcomes the main limitations of vaccinating against mostly unique tumor-resident neoantigens and could represent a simpler vaccination strategy that will be applicable to most patients with cancer.
37
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal et al. · Science · 2016 · 3.1K citations · Full text
Life Sciences, Immunology, Oncology +17
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov et al. · Cell · 2017 · 2.6K citations · Full text
Medicine, Immunology, Oncology +12
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley et al. · Cell · 2017 · 1.3K citations · Full text
Life Sciences, Genetics, Oncology +16
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt et al. · Nature · 2012 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +16
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav, Suchit Jhunjhunwala, Qui Phung et al. · Nature · 2014 · 1.2K citations
Medicine, Immunology, Oncology +16